Medical countermeasures against henipaviruses: a review and public health perspective

Henipaviruses, including Nipah virus, are regarded as pathogens of notable epidemic potential because of their high pathogenicity and the paucity of specific medical countermeasures to control infections in humans. We review the evidence of medical countermeasures against henipaviruses and project t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2022-01, Vol.22 (1), p.e13-e27
Hauptverfasser:	Gómez Román, Raúl, Tornieporth, Nadia, Cherian, Neil George, Shurtleff, Amy C, L’Azou Jackson, Maïna, Yeskey, Debra, Hacker, Adam, Mungai, Eric, Le, Tung Thanh
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Chiroptera - virology Clinical Trials, Phase III as Topic Combined vaccines Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 vaccines Development strategies Disease Outbreaks - prevention & control Disease prevention Disease transmission Encephalitis Epidemics Henipavirus - classification Henipavirus - pathogenicity Henipavirus Infections - drug therapy Henipavirus Infections - prevention & control Henipavirus Infections - transmission Humans Income Infections Infectious diseases Medical Countermeasures Monoclonal antibodies Nipah virus Nipah Virus - pathogenicity Outbreaks Pandemics Pathogenicity Pathogens Public domain Public Health R&D Regulatory agencies Research & development Review SARS-CoV-2 - pathogenicity Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!